Article

Techniques for fertility preservation in patients with breast cancer.

University of Pennsylvania School of Medicine, and Abramson Cancer Center of Univerisity of Pennsylvania, Pennsylvania, USA.
Current opinion in obstetrics & gynecology (Impact Factor: 2.49). 03/2009; 21(1):68-73. DOI: 10.1097/GCO.0b013e32831e13b9
Source: PubMed

ABSTRACT To outline the risks of infertility from breast cancer treatment, and to illustrate current techniques in preserving fertility in breast-cancer patients who wish to become pregnant after treatment is concluded.
Breast cancer often affects women of reproductive age. Although treatment is effective, cytotoxic chemotherapy causes ovarian reserve depletion, whereas hormonal therapy necessitates a delay in pregnancy, resulting in infertility. Patients of reproductive age should be referred to fertility specialists to explore methods of fertility preservation upon diagnosis. The best established method of fertility preservation is embryo cryopreservation, although investigational techniques such as, oocyte and ovarian tissue cryopreservation, may hold potential. Embryo cryopreservation involves ovarian stimulation to retrieve oocytes in-vitro fertilization prior to freezing. Techniques for the cryopreservation of unfertilized oocytes are under investigation. Successful pregnancies have resulted in breast cancer patients after treatment, without obvious compromise in their risk of recurrence or death from breast cancer.
Ovarian stimulation with retrieval of ooctyes for in-vitro fertilization remains the best known option for fertility preservation in women with early stage breast cancer whose risk of fertility may be compromised by adjuvant chemotherapy.

1 Bookmark
 · 
74 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Circa il 2% dei tumori maligni si sviluppa nei primi 18 anni di vita. Nei Paesi occidentali ogni anno un bambino ogni 500, più o meno ugualmente distribuiti nei due sessi, si ammala di tumore. In generale, nel bambino la neoplasia più frequente è rappresentata dal gruppo delle malattie del sangue, comprendente leucemie e linfomi (45%), seguito da tumori del sistema nervoso centrale (22%), neuroblastoma (7%), sarcomi dei tessuti molli (7%) e tumori ossei (6,4%); le percentuali variano ulteriormente secondo la fascia d’età.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanometer scale mechanical processing of semi-insulating GaAs surface was performed using a cantilever oscillating atomic force microscope. Oscillating probe tips induce bond breaking of the GaAs surface and generate nano-meter size patterns. The size of the pattern is shown to be fully controlled by the amplitude and the frequency of the external modulation voltage to the piezo-scanner.
    Japanese Journal of Applied Physics 01/1999; 38:7257-7259. · 1.07 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the United States, more women are diagnosed with breast cancer than any other type of cancer. More than 11,000 of these women will be younger than 40, and many of these women will want to have children in the future. A significant number of these young breast cancer patients will require treatment that can cause ovarian failure or premature menopause. Several options do exist for fertility preservation, both standard and investigational. Embryo cryopreservation is the most established intervention. Investigational interventions include oocyte cryopreservation, ovarian tissue transplantation, ovarian suppression with a gonadotropin-releasing hormone agonist, and harvesting of immature follicles with in vitro maturation and cryopreservation. Although pregnancy during cancer treatment is not recommended, pregnancies occurring after completion of therapy have not been linked to increased cancer recurrence. Young women diagnosed with breast cancer need evidence-based information presented in a timely manner in order to make decisions regarding fertility preservation prior to the initiation of treatment. The oncology advanced practitioner must be knowledgeable about fertility preservation options available to these women as well as comfortable with ethical and financial concerns that can arise. The informed practitioner can effectively counsel patients and refer to fertility specialists when appropriate.
    Journal of the advanced practitioner in oncology. 09/2012; 3(5):289-98.